Case Studies

Treating cancerous tumours with radiotherapy requires precisely targeted treatments to be delivered directly to the cancerous cells without harming surrounding healthy tissue. For example with facilities like gamma knife, up to 200 low power beams, which individually do little harm can be focused to a single area of just a few ...

Magnetic Resonance Imaging (MRI) plays a vital role in diagnosing conditions such as joint, spine and tissue problems, as well as various cancers. Thirty million patients in the EU undergo MRI exams each year. However, 8–10% of the European population have metal implants meaning that additional precautions have to be taken to e...

Low flow-rate drug delivery is required for diabetics, neonates, palliative care and patients in intensive care or undergoing anesthesia. Often, the drugs must be delivered continuously over many hours, and often the amounts prescribed are the maximum that can safely be given. Infusion systems rely on pumps that must be both re...

Developing potential new drugs often involves costly laboratorybased evaluations and drug discovery is currently based on finding new molecules similar to existing ones with known properties. Key to new drug development is an improved understanding of how existing drugs destroy microbe cells and how this relates to the drug’s b...

Molecular radiotherapy (MRT) is often used when other cancer therapies have failed, but it has real potential to be a very effective first line cancer treatment. This therapy directly targets organs with tumours whilst leaving surrounding healthy body tissue unharmed. The treatment uses a range of radioactive drugs to target sp...

For many years molecular radiotherapy (MRT) has been used for palliative care of cancer patients, but it has great potential to become a potent first line cancer treatment. The therapy uses radioactive drugs to target specific tumour locations, for example by injection of radioactive microspheres into tumours in the liver via i...